ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 816

Incomplete Tolerance in Anergic B Cells in SLE: T Helper Signals Restore B Cell Receptor Signaling in Autoreactive Anergic B Cells By Upregulating CD45 Phosphatase Activity

Peter Szodoray1, Stephanie M. Stanford2, Oyvind Molberg3, Nunzio Bottini2 and Britt Nakken1, 1Institute of immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway, 2Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 3Department of Rheumatology, Rikshospitalet, Oslo University Hospital, Oslo, Norway

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: B cell tolerance and SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: We recently identified a human B cell population, which is naturally autoreactive and tolerized by functional anergy. This population was naïve, fully mature, negative for surface IgM and expressing only IgD BCR (BND cells: naïve, D-only). The BND cells have antibody variable region genes in germline configuration and a significant proportion of anergic cells exhibit natural reactivity to antinuclear antigens and dsDNA. Break of B cell tolerance leading to presence of autoantibodies in systemic autoimmune rheumatic diseases may cause the initiation and perpetuation of autoimmune processes. The aim of this study was therefore to investigate if anergy in BND cells could be overcome by T cell mediated signals, as has been reported in murine systems. Furthermore, investigate the molecular mechanisms underlying this process, and determine whether autoreactive BND cells are tolerized in Systemic Lupus Erythematosus  (SLE) patients.

Methods: Untouched naive and BND human B cells from healthy blood donors or SLE patients were purified and cultured in the presence of T cell help (e.g. IL-4 and CD40L) followed by functional assays such as Ca2+-flux, phospho-flow (pSyk, pLyn) and standard flow cytometry measurements of intracellular and surface B cell markers. Finally, CD45 phosphatase activity was measured utilizing a novel fluorescent peptide-based assay.

Results: Here we report that T helper signals reverse the state of anergy allowing BND cells to fully respond to antigenic stimulation by restoring signaling through the B cell receptor. The mechanism was dependent on increased activity of the tyrosine phosphatase CD45, and CD45-dependent activation of Lyn and Syk kinases. CD45 phosphatase activity was upregulated by T cell help both in BND and naïve B cells, suggesting that CD45 is a key regulator of B cell receptor signaling thresholds mediated by T cell help. Furthermore, we found that BND cells obtained from SLE patients exhibited increased CD45 activity and B cell receptor signaling capacity, thus being less tolerized,than BND cells from healthy controls.

Conclusion: We discovered that T helper signals regulate CD45 phosphatase activity in B cells, and that this lead to increased B cell receptor signaling and recovered ability of tolerized BND cells to respond to antigen. Strikingly, we found that BND cells obtained from SLE patients were less tolerized than BND cells from healthy controls. This raises the possibility that BND cells could represent precursors of autoantibody-secreting plasma cells and suggests a role for these autorective B cells in contributing to autoimmunity if not properly controlled. Our data provide new insight in the break of humoral immune tolerance with possible diagnostic and therapeutic implications in patients with SLE and other systemic autoimmune and rheumatic diseases.


Disclosure: P. Szodoray, None; S. M. Stanford, None; O. Molberg, None; N. Bottini, None; B. Nakken, None.

To cite this abstract in AMA style:

Szodoray P, Stanford SM, Molberg O, Bottini N, Nakken B. Incomplete Tolerance in Anergic B Cells in SLE: T Helper Signals Restore B Cell Receptor Signaling in Autoreactive Anergic B Cells By Upregulating CD45 Phosphatase Activity [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/incomplete-tolerance-in-anergic-b-cells-in-sle-t-helper-signals-restore-b-cell-receptor-signaling-in-autoreactive-anergic-b-cells-by-upregulating-cd45-phosphatase-activity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incomplete-tolerance-in-anergic-b-cells-in-sle-t-helper-signals-restore-b-cell-receptor-signaling-in-autoreactive-anergic-b-cells-by-upregulating-cd45-phosphatase-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology